Sakai Chemical Industry : Announcement of New Business Creation Project Launch
September 05, 2023 at 01:54 pm IST
Share
News Release
August 28, 2023
Dear All Concerned
Company Name: Sakai Chemical Industry Co.,
Ltd.
Representative: President and Representative
Director, Toshiyuki Yagura
(Code No.: 4078 TSE Prime)
Inquiries: General Manager of Human Resources
& General Affairs, Toshiki Watanabe
Phone Number: 072-223-4111
Announcement of New Business Creation Project Launch
Sakai Chemical Industry Co., Ltd. is pleased to announce the launch of a new business creation project as of August 28, 2023.
1. Background
On August 23, 2023, Sakai Chemical Industry made Sakai Trading Co., Ltd. a wholly-owned subsidiary. One objective behind making Sakai Trading Co., Ltd. a wholly-owned subsidiary is to acquire new customers and enter new domains by leveraging Sakai Trading's agility to create new businesses. To achieve this, we will launch a project to concentrate the management resources of the Sakai Chemical Group and create new businesses not bound by existing businesses.
2. Project Overview
We will launch a project to conduct marketing that creates value and success through unprecedented ideas, aiming to create new businesses not bound by existing businesses by concentrating the management resources of the Sakai Chemical Group. A virtual organization will be established in Sakai Trading Co., Ltd., to bring together human resources who understand the traits of each group company to conduct research and offer solutions to create new business.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sakai Chemical Industry Co. Ltd. published this content on 05 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 September 2023 08:23:08 UTC.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.